Eleftha 440 Mg Injection

Description

It is a chemotherapy drug that works by inhibiting certain enzymes essential for cancer cell growth and replication. By interfering with these processes, Eleftha helps to slow down or stop the progression of specific types of cancer. It is primarily indicated for the treatment of non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. The dosage and administration of Eleftha 440mg Injection are determined by a qualified healthcare professional based on the patient’s condition, response to treatment, and other individual factors. Common side effects may include fatigue, nausea, vomiting, loss of appetite, hair loss, and myelosuppression (low blood cell counts). Patients may also experience mouth sores, diarrhea, and skin rash. It is crucial to report any unusual or severe side effects to your doctor immediately. Eleftha 440mg Injection should be stored at room temperature, protected from light, and kept out of reach of children. It is administered intravenously by a healthcare provider.